Assessed adverse events among the four treatment arms during a randomized, placebo-controlled trial carried out on Pemba Island, Tanzania.

Adverse events were assessed at five different time points (before treatment, 3 and 24 hours after first treatment, and 3 and 24 hours after second treatment). Nitazoxanide was given on the first day of treatment, while albendazole was given on the second day of treatment.*statistically significant more adverse events in nitazoxanide-treated children compared to children receiving placebo.aOne of these adverse events was classified as moderate.